biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Deal is only option....we won't like the alternative..

<< Previous

Bullboard Posts

Next >>

Post by OysterBuctoucheon Dec 22, 2022 5:03pm

172 Views

Post# 35188109

Deal is only option....we won't like the alternative..

Pass this deal or else it would seem. Facing Chapter 11...Nobody likes this deal. But new leadership /new lease on life. Gotta move on let the new team pursude the deals. Time to move on..

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments